Daniel Harris Gura, PharmD, MPH
Summary
Experienced professional with 25 years in Healthcare and Emerging Tech Business Development, R&D/Sales, and Investments. Proven track record in cultivating and scaling strategic partnerships within digital health, medical devices, healthcare SAAS, climate tech, and AI startups.
Overview
32
32
years of professional experience
Work History
Consultant/Director of Business Development, AI, Healthcare, Clean-Tech
Hugo Neu
01.2021 - Current
- Spearheading innovation and R&D initiatives to identify and invest in Seed to Series A startups
- Sourced and Identified strategic business opportunities at private family office in alignment with Hugo Neu's mission and business goals to support renewable energy, food tech, climate tech, digital health, and sustainability.
- Evaluating an average of 100+ startup companies monthly as potential investments, offering business resources for their growth.
- Cultivating strong relationships with regional venture capital firms, accelerators, incubators, and universities to source healthcare and renewable energy innovation.
- Director of Ocean Pathways Mentorship Program for Blue Economy Initiatives
- NJEDA CSIT Subject Matter Expert in Healthcare and Climate Technologies
- Better Future Labs AI, Healthcare Consultant
- Mentor for Tech United Minority Women Business Enterprise Program
- Mentor for Rutgers University Externship Program
- AI consultant for Lumio AI, Licentiam AI, RegKey AI, Glezcetch AI, Carepoint AI Mobile App
- Small business consultant for NJ Ecosystem Startups: Ciel Power, Polygone Systems, BoomID, VOX Telehealth, Eye-Guide, Taste of Caribbean, Pooka, Syenz Lab, Wex Energy, The Terpene Store
Consultant/Director of Business Development, Healthcare & Emerging Technologies
Heller Industries
01.2015 - 01.2021
- Led business development efforts and strategic intelligence for investments in emerging technologies, with a focus on digital healthcare applications and flexible hybrid electronics
- Assisted in securing $3M in seed capital for a NJ based electronic adhesive company
- Managed R&D pipeline to procure non-dilutive funding opportunities; annual pipeline worth $20M
- Interim CEO and Director of Business Development for AlgometRx, Inc., a digital biometric health startup; seed capital raise of $2.5M and $410,000 in non-dilutive grant funding; $8M ARPA-H grant to study pain in women.
- Led and supported AlgometRx's selection for the Johnson & Johnson JLABS Residency program (2019) and winning the FDA Opioid Use Disorder Innovation Challenge (2018)
Director of Business Development, Healthcare
CommGeniX
01.2007 - 01.2014
- Managed pharmaceutically sponsored programs and educational content for healthcare practitioners and patients dealing with chronic pain, managing a $30 million pipeline.
- Led development and implementation a patient-reported outcome mobile electronic diary for pain management.
- Implemented the first online cancer pain forum on Doximity, a multi-billion-dollar social network for physicians, to address opioid use, misuse, and addiction.
- Established and secured strategic relationships with key opinion leaders in oncology and pain management
Associate Scientific Director, Healthcare
Geriatric Oncology Consortium
01.2004 - 01.2007
- Screened, recruited, and managed a network of 200+ community-based oncology physician practice sites for selection in clinical trials
- Led business development for pharmaceutical-sponsored clinical trials and medical education programs
Clinical Research Associate, Healthcare
MD Anderson Cancer Center
01.1994 - 01.1998
- Directed bilingual cancer and phantom limb clinical pain study in pediatric and adult populations
- Worked as a research assistant in phase II-III clinical trials in cancer pain analgesics
- Department of Pain and Symptom Management
Education
Boehringer-Ingelheim Post-Doctoral Research Fellow - Health Economics
Yale University School of Medicine/Public Health
01.2004
Doctor of Pharmacy - undefined
The University of Texas at Austin, College of Pharmacy
01.2002
Master of Public Health - undefined
The University of Texas Health Science Center at Houston, School of Public Health
01.1998
B.A. - Art History
Swarthmore College
Swarthmore, Pa01.1991
Skills
- Strategic thinking
- Innovation strategy
- Lean startup
- Partnership development
- Intellectual property
- Proposal writing
- Value proposition design
Publications
- J.T. Tam, R. Hauser, D. Gura, A. Paraghamian, H. Thomas, S. Lichtman Has Demand Outpaced Supply for Clinical Trial Participants? Journal of Clinical Oncology, 2006; ASCO Annual Meetings Proceeds Part I. Vol. 24, No. 185 (June 20 Supplement), 2006.
- Weinfeld AB, Yuksel E, Boutros S, Gura DH, Akyurek M, Friedman JD. Clinical and scientific considerations in leech therapy for the management of acute venous congestion: an updated review. Ann Plast Surg. 2000 Aug; 45(2):207-12.
- Shenaq SM, Kattash MM, Weinfeld AB, Waugh JM, Yuksel E, Yuksel M, Gura DH. Local gene delivery: arterial thrombosis model for endothelial cell-targeted thrombolytic gene therapy research. J Reconstr Microsurg. 1999 Jan; 15(1):73-9.
- Sharon M. Weinstein, Daniel Gura, Suresh K. Reddy; M.D. Anderson Cancer Center, “Field Test of the IASP Classification of Chronic Pain Coding System,” Fifteenth Annual Scientific Meeting American Pain Society, Washington, DC, November 14-17, 1996.
- S.M. Weinstein, D.H. Gura, K.K. Stuebing, University of Texas M.D. Anderson Cancer Center, “Onset of Post amputation Phantom Limb Pain: Results of a Perspective Survey,” 8th World Congress on Pain, Vancouver, BC, Canada, August 17-22, 1996.
- Sharon M. Weinstein, M.D., Daniel Gura BA, Suresh K Reddy, M.D., “Assessment of Post- Amputation Stump and Phantom Limb Pain in Children: Use of the Wisconsin Brief Pain Inventory,” Pediatric Pain Challenges, Innovations, and Costs Program. Sponsored by the Egleston Children’s Hospital at Emory University, Atlanta, Georgia, November 4, 1995.
Timeline
Consultant/Director of Business Development, AI, Healthcare, Clean-Tech
Hugo Neu
01.2021 - Current
Consultant/Director of Business Development, Healthcare & Emerging Technologies
Heller Industries
01.2015 - 01.2021
Director of Business Development, Healthcare
CommGeniX
01.2007 - 01.2014
Associate Scientific Director, Healthcare
Geriatric Oncology Consortium
01.2004 - 01.2007
Clinical Research Associate, Healthcare
MD Anderson Cancer Center
01.1994 - 01.1998
Doctor of Pharmacy - undefined
The University of Texas at Austin, College of Pharmacy
Master of Public Health - undefined
The University of Texas Health Science Center at Houston, School of Public Health
B.A. - Art History
Swarthmore College
Boehringer-Ingelheim Post-Doctoral Research Fellow - Health Economics
Yale University School of Medicine/Public Health
Similar Profiles
Connie ClarkConnie Clark
Receptionist at Neu Urgent Care / Neu HopeReceptionist at Neu Urgent Care / Neu Hope
Mia PerkinsMia Perkins
Event Coordinator Assistant at Neu EventsEvent Coordinator Assistant at Neu Events
YADANG Linda ElieYADANG Linda Elie
International Business Development Executive at NEU Micromed PvtInternational Business Development Executive at NEU Micromed Pvt
Doug RubinoDoug Rubino
Business Development Director, Healthcare at DataMotionBusiness Development Director, Healthcare at DataMotion
Colette BukowskiColette Bukowski
Associate Director, Business Development Behavioral Healthcare and Human Services at The Joint CommissionAssociate Director, Business Development Behavioral Healthcare and Human Services at The Joint Commission